Diagnosis, Management, and Outcome of Stroke Infark
A Ten Years Systematic Review
Keywords:
antiplatelet therapy, ischemic stroke, ticagrelor, ginkgoAbstract
Background: Treatment for Ischemic stroke has shown promising results with antiplatelet therapy and ginkgo biloba extracts, but clopidogrel and aspirin resistance may increase bleeding risk. Ticagrelor, a novel antiplatelet drug, shows efficacy. Methods: Using the PRISMA 2020 principles, this systematic review concentrated on full-text English literature published between 2014 and 2024. Among other internet resources, PubMed, ScienceDirect, and SagePub were used to compile the literature. Result: Following a thorough three-level screening process, six publications were determined to be closely connected to our current comprehensive review. Following that, an extensive examination of the entire text was carried out, and these articles were subjected to further inspection. Conclusion: Antiplatelet therapy's efficacy and safety in treating ischemic stroke are limited due to short symptom onset, high price, and low accessibility. Combining antiplatelet therapy with rt-PA for better outcomes is recommended. Neuroprotective agents like ginkgo diterpene lactone meglumine show potential for improving functional outcomes and reducing bleeding risks.
References
Hui C, Tadi P, Patti L. Ischemic Stroke. [Updated 2022 Jun 2]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499997/
Aref, H. M., El-Khawas, H., Elbassiouny, A., Shokri, H. M., Zeinhom, M. G., & Roushdy, T. M. (2023). A randomized pilot study of the efficacy and safety of loading ticagrelor in acute ischemic stroke. Neurological Sciences, 44(2), 765–771. https://doi.org/10.1007/s10072-022-06525-7
Ntaios, G. (2020). Embolic Stroke of Undetermined Source: JACC Review Topic of the Week. Journal of the American College of Cardiology, 75(3), 333–340. https://doi.org/10.1016/j.jacc.2019.11.024
Pierik, R., Algra, A., Van Dijk, E., Erasmus, M. E., Van Gelder, I. C., Koudstaal, P. J., Luijckx, G. J. R., Nederkoorn, P. J., Van Oostenbrugge, R. J., Ruigrok, Y. M., Scheeren, T. W. L., Uyttenboogaart, M., Visser, M. C., Wermer, M. J. H., & Van Den Bergh, W. M. (2020). Distribution of Cardioembolic Stroke: A Cohort Study. Cerebrovascular Diseases, 49(1), 97–104. https://doi.org/10.1159/000505616
Liu, X., Lv, X., Peng, Y., Wang, J., Lei, J., Tang, C., Luo, S., Mai, W., Cai, Y., Fan, Q., Liu, C., & Zhang, L. (2024). Clopidogrel with indobufen or aspirin in minor ischemic stroke or high-risk transient ischemic attack: a randomized controlled clinical study. BMC Neurology, 24(1), 1–10. https://doi.org/10.1186/s12883-024-03585-4
Chen, J., Lin, Y., Li, J., Zhang, P., Wang, Y., Chen, Y., Zhang, C., & Li, C. (2023). Efficacy and safety of short-term high dosage dual antiplatelet therapy after 0.6 mg/kg rt-PA intravenous thrombolysis for acute ischemic stroke. Medicine (United States), 102(36), E35099. https://doi.org/10.1097/MD.0000000000035099
Johnston, S. C., Amarenco, P., Albers, G. W., Denison, H., Easton, J. D., Held, P., Jonasson, J., Minematsu, K., Molina, C. A., & Wong, L. K. S. (2015). Acute stroke or transient ischemic attack treated with aspirin or ticagrelor and patient outcomes (SOCRATES) trial: Rationale and design. International Journal of Stroke, 10(8), 1304–1308. https://doi.org/10.1111/ijs.12610
Johnston, S. C., Amarenco, P., Denison, H., Evans, S. R., Himmelmann, A., James, S., Knutsson, M., Ladenvall, P., Molina, C. A., & Wang, Y. (2020). Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA. New England Journal of Medicine, 383(3), 207–217. https://doi.org/10.1056/nejmoa1916870
Zhang, Q., Wang, A., Xu, Q., Xia, X., Tian, X., Zhang, Y., Li, X., Yang, X., Wang, X., Peng, J., Li, Y., Liu, L., Jin, S., Meng, X., & Zhao, X. (2023). Efficacy and Safety of Ginkgo Diterpene Lactone Meglumine in Acute Ischemic Stroke: A Randomized Clinical Trial. JAMA Network Open, 6(8), e2328828. https://doi.org/10.1001/jamanetworkopen.2023.28828
Fan, X. X., Cao, Z. Y., Liu, M. X., Liu, W. J., Xu, Z. L., Tu, P. F., Wang, Z. Z., Cao, L., & Xiao, W. (2021). Diterpene Ginkgolides Meglumine Injection inhibits apoptosis induced by optic nerve crush injury via modulating MAPKs signaling pathways in retinal ganglion cells. Journal of Ethnopharmacology, 279(June), 114371. https://doi.org/10.1016/j.jep.2021.114371
Zhao, S., Zheng, H., Du, Y., Zhang, R., Chen, P., Ren, R., & Wu, S. (2021). The Clinical Efficacy of Ginkgo biloba Leaf Preparation on Ischemic Stroke: A Systematic Review and Meta-Analysis. Evidence-Based Complementary and Alternative Medicine, 2021, 1–10. https://doi.org/10.1155/2021/4265219
Liu, L., Xie, X., Pan, Y., Wang, A., Wei, Y., Liu, J., Nie, X., Liu, D., Zhao, Z., Wang, P., Shen, S., Zhong, C., Xu, T., Wang, D., Wang, G. C., Song, D., Ma, Y., Zhao, J., Jiang, Y., … He, J. (2023). Early versus delayed antihypertensive treatment in patients with acute ischaemic stroke: multicentre, open label, randomised, controlled trial. Bmj, 1–12. https://doi.org/10.1136/bmj-2023-076448
Anderson, C. S., Huang, Y., Lindley, R. I., Chen, X., Arima, H., Chen, G., Li, Q., Billot, L., Delcourt, C., Bath, P. M., Broderick, J. P., Demchuk, A. M., Donnan, G. A., Durham, A. C., Lavados, P. M., Martins, S. O., Olavarria, V. V., Pandian, J. D., Parsons, M. W., … Van, D. N. (2019). Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial. The Lancet, 393(10174), 877–888. https://doi.org/10.1016/S0140-6736(19)30038-8
Benali, F., Singh, N., Fladt, J., Jaroenngarmsamer, T., Bala, F., Ospel, J. M., Buck, B. H., Dowlatshahi, D., Field, T. S., Hanel, R. A., Peeling, L., Tymianski, M., Hill, M. D., Goyal, M., & Ganesh, A. (2024). Mediation of Age and Thrombectomy Outcome by Neuroimaging Markers of Frailty in Patients with Stroke. JAMA Network Open, 7(1), 1–13. https://doi.org/10.1001/jamanetworkopen.2023.49628
Cassella, C. R., & Jagoda, A. (2017). Ischemic Stroke: Advances in Diagnosis and Management. Emergency Medicine Clinics of North America, 35(4), 911–930. https://doi.org/10.1016/j.emc.2017.07.007
Amarenco, P., Albers, G. W., Denison, H., Easton, J. D., Evans, S. R., Held, P., Hill, M. D., Jonasson, J., Kasner, S. E., Ladenvall, P., Minematsu, K., Molina, C. A., Wang, Y., Wong, K. S. L., & Johnston, S. C. (2017). Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial. The Lancet Neurology, 16(4), 301–310. https://doi.org/10.1016/S1474-4422(17)30038-8
Xu, J., Zhang, Y., Wei, H., Xu, Y., Wang, M., Cai, Z., & Li, X. (2015). A comparison of rt-PA thrombolysis guidelines between China and the USA: Are changes needed? Neurological Research, 37(1), 57–63. https://doi.org/10.1179/1743132814Y.0000000415
Wang, Y., Pan, Y., Zhao, X., Li, H., Wang, D., Johnston, S. C., Liu, L., Meng, X., Wang, A., Wang, C., & Wang, Y. (2015). Clopidogrel with aspirin in acute minor stroke or transient ischemic attack (CHANCE) trial one-year outcomes. Circulation, 132(1), 40–46. https://doi.org/10.1161/CIRCULATIONAHA.114.014791
Wang, Y., Wang, Y., Zhao, X., Liu, L., Wang, D., Wang, C., Wang, C., Li, H., Meng, X., Cui, L., Jia, J., Dong, Q., Xu, A., Zeng, J., Li, Y., Wang, Z., Xia, H., & Johnston, S. C. (2013). Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack. New England Journal of Medicine, 369(1), 11–19. https://doi.org/10.1056/nejmoa1215340
P Johnston, S. C., Easton, J. D., Farrant, M., Barsan, W., Conwit, R. A., Elm, J. J., Kim, A. S., Lindblad, A. S., & Palesch, Y. Y. (2018). Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. New England Journal of Medicine, 379(3), 215–225. https://doi.org/10.1056/nejmoa1800410
Wang, Y., Liu, M., & Pu, C. (2017). 2014 Chinese guidelines for secondary prevention of ischemic stroke and transient ischemic attack: Compiled by the Chinese Society of Neurology, Cerebrovascular Disease Group. International Journal of Stroke, 12(3), 302–320. https://doi.org/10.1177/1747493017694391
Lee, M., Ovbiagele, B., Hong, K. S., Wu, Y. L., Lee, J. E., Rao, N. M., Feng, W., & Saver, J. L. (2015). Effect of Blood Pressure Lowering in Early Ischemic Stroke: Meta-Analysis. Stroke, 46(7), 1883–1889. https://doi.org/10.1161/STROKEAHA.115.009552
Lin, K. H., Lin, H. J., & Yeh, P. S. (2022). Determinants of Prolonged Length of Hospital Stay in Patients with Severe Acute Ischemic Stroke. Journal of Clinical Medicine, 11(12), 0–7. https://doi.org/10.3390/jcm11123457
Zhu, P. C., Tong, Q., Zhuang, Z., Wang, Z. H., Deng, L. H., Zheng, G. Q., & Wang, Y. (2019). Ginkgolide b for myocardial ischemia/reperfusion injury: A preclinical systematic review and meta-analysis. Frontiers in Physiology, 10(OCT). https://doi.org/10.3389/fphys.2019.01292
Lauksio, I., Lindström, I., Khan, N., Sillanpää, N., Hernesniemi, J., Oksala, N., & Protto, S. (2021). Brain atrophy predicts mortality after mechanical thrombectomy of proximal anterior circulation occlusion. Journal of NeuroInterventional Surgery, 13(5), 415–420. https://doi.org/10.1136/neurintsurg-2020-016168
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Stevanie S Halim, Nanda Ayu Zaskia (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors publishing here keep copyright but grant the journal first publication rights, under a Creative Commons Attribution-NonCommercial 4.0 License. They can distribute their work non-exclusively elsewhere with an acknowledgment of its first publication in this journal. Posting the work online before and during submission for earlier and greater citation is encouraged, reflecting Open Access benefits.
